Patent details

301226 Product Name: Midazolam HCI, in de vorm van een ethanol/propyleenglycol solubilisaat

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301226
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1703896
Status:
Application Pending
Application number:
301226
Procedural language:
Dutch
First Applicant Residence Country:
Belgium (BE)

Marketing Authorization

1

Marketing Authorization Number:
RVG126266; RVG126267; RVG126268
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
13/10/2022
Marketing Authorization Country:
Netherlands (NL)

2

Marketing Authorization Number:
MTnr 20-13328; MTnr. 20-13329; Mtnr. 20-13330
Marketing Authorization Type:
EEA
Marketing Authorization Date:
22/09/2022
Marketing Authorization Country:
Norway (NO)

Dates

Filing date:
12/04/2023
First Marketing Authorization date:
22/09/2022
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
13/04/2023
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
12/04/2023
 
 

 

Name:
F.W.H.M. Merkus
Address:
Grootreesdijk 26, 2460, Kasterlee, Belgium (BE)

Agent

Name:
dr. R.C. van Duijvenbode c.s.
From:
12/04/2023
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

Bulletin Heading:
SPC
Journal edition number:
16/23
Publication date:
19/04/2023
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date Document type Document Description Number of pages File Type
13/04/2023 Outgoing Correspondence Confirmation receipt request 1 PDF /2/3/9/7/6/0800867932/docs/301226_7_541162l174.pdf
12/04/2023 Application Form First filed application form 2 PDF /2/3/9/7/6/0800867932/docs/301226_0_applicationform20230413032005191.pdf
12/04/2023 SPC Documents Summary of the characteristics of the product 19 PDF /2/3/9/7/6/0800867932/docs/301226_1_supplprotectioncertificate20230413032251068.pdf
12/04/2023 SPC Documents Marketing Authorization SPC 1 PDF /2/3/9/7/6/0800867932/docs/301226_2_supplprotectioncertificate20230413032135796.pdf
12/04/2023 SPC Documents Marketing Authorization SPC 1 PDF /2/3/9/7/6/0800867932/docs/301226_3_supplprotectioncertificate20230413032340772.pdf
12/04/2023 SPC Documents Marketing Authorization SPC 1 PDF /2/3/9/7/6/0800867932/docs/301226_4_supplprotectioncertificate20230413032201411.pdf
12/04/2023 SPC Documents Marketing Authorization SPC 2 PDF /2/3/9/7/6/0800867932/docs/301226_5_supplprotectioncertificate20230413032316796.pdf
12/04/2023 SPC Documents Accompanying letter SPC 1 PDF /2/3/9/7/6/0800867932/docs/301226_6_supplprotectioncertificate20230413032413840.pdf